Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07461857 · ClinicalTrials.gov registry record · NA
Minority-focused Environmental Health Education and Tracking Pilot Study
A NA study, sponsored by Million Marker Wellness.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT07461857: Completed NA study, sponsored by Million Marker Wellness.
NCT07461857 is a NA study that has completed, run by Million Marker Wellness. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07461857, a NA study, has completed, sponsored by Million Marker Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The goal of this study is identify educational material related to EDC exposures that is culturally appropriate for the black community and test the usability of the material. The main questions this study aims to answer are: 1. identify problematic lifestyle behaviors and products in a minority population that may contribute to harmful exposures and subsequently determine the most effective and sustainable lifestyle recommendations to reduce exposures; 2. develop culturally appropriate educational EDC EHL materials by collaborating with community groups and adapting from Million Marker's existing extensive online educational resources and recommendations; 3. integrate developed educational materials and targeted recommendations in existing Million Marker platform and test the usability of the material using a cohort of 100 black community members.
Primary Outcome
This surveys assesses EDC-specific environmental health literacy, based on questions in a 5-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) or 1 (never) to 5 (always). Responses will be reverse coded during analysis as needed so that higher numbers reflect positive outcomes (higher EDC-EHL).
Interventions
- BEHAVIORAL Education curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2026-02-20 |
| Phase | NA |
What the finished NCT07461857 record still lists
NCT07461857 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Education curriculum is the first listed.
NCT07461857 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07461857 about?
NCT07461857 is a clinical study titled "Minority-focused Environmental Health Education and Tracking Pilot Study". The goal of this study is identify educational material related to EDC exposures that is culturally appropriate for the black community and test the usability of the material. The main questions this study aims to answer are: 1. identify problematic lifestyle behaviors and products in a minority po...
What is the current status of trial NCT07461857?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2025-09-01. Estimated completion is 2026-02-20.
What interventions are being tested in trial NCT07461857?
The interventions under investigation include: Education curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT07461857?
This trial is sponsored by Million Marker Wellness, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07461857's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI